A detailed history of Us Bancorp \De\ transactions in X Biotech Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 100 shares of XBIT stock, worth $373. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 100 -0.0%
Holding current value
$373
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

BUY
$4.54 - $9.89 $454 - $989
100 New
100 $0
Q4 2021

Feb 11, 2022

SELL
$10.95 - $16.07 $4,927 - $7,231
-450 Closed
0 $0
Q2 2021

Aug 05, 2021

SELL
$15.83 - $17.84 $1,108 - $1,248
-70 Reduced 13.46%
450 $7,000
Q3 2020

Nov 10, 2020

SELL
$13.97 - $21.16 $17,043 - $25,815
-1,220 Reduced 70.11%
520 $10,000
Q2 2020

Aug 07, 2020

BUY
$10.39 - $16.07 $18,078 - $27,961
1,740 New
1,740 $24,000

Others Institutions Holding XBIT

About XBiotech Inc.


  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $114M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.